News

Featured

Gut feelings: how what you eat could be affecting your health - and what to do about it

How does our everyday diet influence how we feel, and could a few simple changes really make a difference?

Featured

A Design for Life: is scleroderma in the genes?

What is the link between our genetic code and developing scleroderma? Researchers from Spain have recently studied genetic alterations and established a connection with the pathways that dictate the clinical features of scleroderma. The study is significant because increasing our understanding of the genetic pathway could be a faster route towards identifying effective new therapies for this complex condition.

Featured

Open Research - revolutionising the publishing process for SRUK research

SRUK is working with our partners at the Association of Medical Research Charities via their new Open Research Platform, to revolutionise the publishing process for our researchers. This will enable SRUK-funded research groups to publish their work in a streamlined and cost-effective way, with the ultimate goal of translating new knowledge into effective treatments for people living with scleroderma.

Tuesday 26th April 2016

M10 Peptide Shows Anti-Fibrotic Activity in Mice

Researchers recently discovered a natural molecule, the M10 peptide, that can significantly decrease fibrosis in a mouse model of scleroderma.

Read Article

Tuesday 19th April 2016

Largest scleroderma study to date has created a complete genetic map of the disease

Read Article

Friday 15th April 2016

How I Manage My Auto Immune Diseases Without Medication

Well! It’s not easy but I have managed it with a few changes over the years to my nutrition and a good exercise plan.

Read Article

Thursday 14th April 2016

What Exactly is 'Pre-Scleroderma'?

Read Article

Tuesday 12th April 2016

Endothelin-1 Receptor Blockers Again Shown to Be Ineffective in Treating Skin Fibrosis

Read Article

Saturday 2nd April 2016

What is research doing for me?

Prof. Denton, Consultant Rheumatologist at the Royal Free Hospital, London opened the World Systemic Sclerosis Congress with a presentation on 'What is research doing for me?' This uplifting and informative presentation highlighted the positive breakthroughs taking place in scleroderma research.

Read Article

Wednesday 30th March 2016

Halfway Point Marked in Scleroderma Patient Enrolment for Cytori's ECCS-50 Phase 3 Trial

Cytori Therapeutics has enrolled and treated its 40th patient with scleroderma in the Phase 3 STAR clinical trial for ECCS-50, marking 50 percent of target enrollment.

Read Article